This article provides a comprehensive analysis of the burgeoning field of CRISPR/Cas9-engineered regulatory T cells (Tregs) for cancer immunotherapy.
This article provides a comprehensive guide for researchers on utilizing CRISPR-Cas9 functional genomics screens to identify the genetic drivers of chemoresistance in cancer stem cells (CSCs).
This comprehensive guide explores the application of CRISPR-Cas9 functional genomics screening to dissect the roles of cancer stem cell (CSC) markers in tumor initiation, progression, and therapy resistance.
This article provides a comprehensive guide to using CRISPR-based functional genomics screens to identify and validate mechanisms of immune evasion within the tumor microenvironment (TME).
This article provides a detailed overview of CRISPR screening for cancer drug target discovery, tailored for researchers, scientists, and drug development professionals.
This article provides researchers and drug development professionals with a comprehensive guide to using CRISPR-based screening for identifying and validating cancer stem cell (CSC) markers.
This article provides a comprehensive technical analysis of CRISPR base editing and prime editing platforms for the precise correction of oncogenic mutations.
This comprehensive review compares the efficiency, precision, and practical application of CRISPR-Cas9 and TALENs for gene editing in cancer research and drug development.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on leveraging CRISPR-Cas9 somatic cell genome editing for advanced cancer modeling.
This protocol article provides a comprehensive, step-by-step guide for researchers and drug development professionals on utilizing CRISPR-Cas9 gene editing to engineer chimeric antigen receptor (CAR) T cells.